151 related articles for article (PubMed ID: 29559345)
21. Cyclosporine treatment for Stevens-Johnson syndrome/toxic epidermal necrolysis: Retrospective analysis of a cohort treated in a specialized referral center.
Lee HY; Fook-Chong S; Koh HY; Thirumoorthy T; Pang SM
J Am Acad Dermatol; 2017 Jan; 76(1):106-113. PubMed ID: 27717620
[TBL] [Abstract][Full Text] [Related]
22. New Evidence Supporting Cyclosporine Efficacy in Epidermal Necrolysis.
Roujeau JC; Mockenhaupt M; Guillaume JC; Revuz J
J Invest Dermatol; 2017 Oct; 137(10):2047-2049. PubMed ID: 28941473
[TBL] [Abstract][Full Text] [Related]
23. Cyclosporine Use in Epidermal Necrolysis Is Associated with an Important Mortality Reduction: Evidence from Three Different Approaches.
González-Herrada C; Rodríguez-Martín S; Cachafeiro L; Lerma V; González O; Lorente JA; Rodríguez-Miguel A; González-Ramos J; Roustan G; Ramírez E; Bellón T; de Abajo FJ;
J Invest Dermatol; 2017 Oct; 137(10):2092-2100. PubMed ID: 28634032
[TBL] [Abstract][Full Text] [Related]
24. Pediatric Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Halted by Etanercept.
Gavigan GM; Kanigsberg ND; Ramien ML
J Cutan Med Surg; 2018; 22(5):514-515. PubMed ID: 29421925
[TBL] [Abstract][Full Text] [Related]
25. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
[TBL] [Abstract][Full Text] [Related]
26. [Reply to the article "treatment of toxic epidermal necrolysis with cyclosporine A"].
Cachafeiro L; Sánchez M; Leyva F; García de Lorenzo A
Med Intensiva; 2012; 36(5):382. PubMed ID: 22560154
[No Abstract] [Full Text] [Related]
27. Cyclosporine in SJS/TEN management: a brief review.
Shokeen D
Cutis; 2016 Mar; 97(3):E17-8. PubMed ID: 27023091
[TBL] [Abstract][Full Text] [Related]
28. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.
Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M
Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483
[TBL] [Abstract][Full Text] [Related]
29. Incidence and Triggers of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in a Large Cancer Patient Cohort.
Gillis NK; Hicks JK; Bell GC; Daly AJ; Kanetsky PA; McLeod HL
J Invest Dermatol; 2017 Sep; 137(9):2021-2023. PubMed ID: 28549953
[No Abstract] [Full Text] [Related]
30. Cyclosporine-induced toxic leukoencephalopathy in toxic epidermal necrolysis.
Kaushik A; Kumaran MS; Vinay K; Mehta S; Singh P
Int J Dermatol; 2019 Feb; 58(2):e36-e38. PubMed ID: 30456813
[No Abstract] [Full Text] [Related]
31. Corticosteroids in Stevens-Johnson Syndrome/toxic epidermal necrolysis: current evidence and implications for future research.
Law EH; Leung M
Ann Pharmacother; 2015 Mar; 49(3):335-42. PubMed ID: 25406459
[TBL] [Abstract][Full Text] [Related]
32. Cyclosporine in Stevens Johnson syndrome and toxic epidermal necrolysis and retrospective comparison with systemic corticosteroid.
Singh GK; Chatterjee M; Verma R
Indian J Dermatol Venereol Leprol; 2013; 79(5):686-92. PubMed ID: 23974585
[TBL] [Abstract][Full Text] [Related]
33. Pediatric toxic epidermal necrolysis treated successfully with infliximab.
Chafranska L; Saunte DM; Behrendt N; Nygaard U; Christensen RJ; Sand C; Jemec GB
Pediatr Dermatol; 2019 May; 36(3):342-345. PubMed ID: 30834560
[TBL] [Abstract][Full Text] [Related]
34. [Use of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis and Stevens-Johnson/toxic epidermal necrolysis overlap syndrome. Review of 15 cases].
Molgó M; Carreño N; Hoyos-Bachiloglu R; Andresen M; González S
Rev Med Chil; 2009 Mar; 137(3):383-9. PubMed ID: 19621180
[TBL] [Abstract][Full Text] [Related]
35. [Stevens-Johnson syndrome and toxic epidermal necrolysis: retrospective study of 185 cases in Abidjan (Côte d'Ivoire)].
Kourouma S; Sangaré A; Kaloga M; Kouassi I; Ecra E; Gbery I; Ahogo C; Kouassi A; Kassi K; Camara B
Med Sante Trop; 2014; 24(1):94-8. PubMed ID: 24736218
[TBL] [Abstract][Full Text] [Related]
36. The use of cyclosporine for Stevens-Johnson syndrome-toxic epidermal necrolysis spectrum at the University of Louisville: A case series and literature review.
Conner CD; McKenzie E; Owen CE; Callen JP
Dermatol Online J; 2018 Jan; 24(1):. PubMed ID: 29469760
[TBL] [Abstract][Full Text] [Related]
37. Thalidomide in toxic epidermal necrolysis.
Klausner JD; Kaplan G; Haslett PA
Lancet; 1999 Jan; 353(9149):324. PubMed ID: 9929047
[No Abstract] [Full Text] [Related]
38. Genitourinary involvement and management in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Van Batavia JP; Chu DI; Long CJ; Jen M; Canning DA; Weiss DA
J Pediatr Urol; 2017 Oct; 13(5):490.e1-490.e7. PubMed ID: 28314701
[TBL] [Abstract][Full Text] [Related]
39. Cyclosporine in toxic epidermal necrolysis: a brief review of the emerging therapeutic modality.
Kumar P; Kanti Das N
Dermatol Online J; 2016 Oct; 22(10):. PubMed ID: 28329582
[TBL] [Abstract][Full Text] [Related]
40. Toxic epidermal necrolysis associated with severe hypocalcaemia, and treated with cyclosporin.
Zaki I; Patel S; Reed R; Dalziel KL
Br J Dermatol; 1995 Aug; 133(2):337-8. PubMed ID: 7547417
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]